Header Logo

Connection

FELIPE SAMANIEGO to Bone Density Conservation Agents

Back to Details
This is a "connection" page, showing publications FELIPE SAMANIEGO has written about Bone Density Conservation Agents.
FELIPE SAMANIEGO
Connection Strength
0.096
Bone Density Conservation Agents
  1. Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial. Clin Lymphoma Myeloma Leuk. 2013 Apr; 13(2):99-105.
    View in: PubMed
    Score: 0.096
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.